BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28404532)

  • 1. Cost-effectiveness and cost utility of community screening for glaucoma in urban India.
    John D; Parikh R
    Public Health; 2017 Jul; 148():37-48. PubMed ID: 28404532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of community screening for glaucoma in rural India: a decision analytical model.
    John D; Parikh R
    Public Health; 2018 Feb; 155():142-151. PubMed ID: 29407529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.
    Burr JM; Mowatt G; Hernández R; Siddiqui MA; Cook J; Lourenco T; Ramsay C; Vale L; Fraser C; Azuara-Blanco A; Deeks J; Cairns J; Wormald R; McPherson S; Rabindranath K; Grant A
    Health Technol Assess; 2007 Oct; 11(41):iii-iv, ix-x, 1-190. PubMed ID: 17927922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for refractive error and fitting with spectacles in rural and urban India: cost-effectiveness.
    Frick KD; Riva-Clement L; Shankar MB
    Ophthalmic Epidemiol; 2009; 16(6):378-87. PubMed ID: 19995203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
    Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N
    Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis.
    Xiao X; Xue L; Ye L; Li H; He Y
    BMC Public Health; 2021 Jun; 21(1):1065. PubMed ID: 34088286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costing a community based screening programme for the detection of glaucoma.
    Jones SJ; Vernon SA; Cater L; Henry DJ
    Eye (Lond); 1990; 4 ( Pt 1)():98-102. PubMed ID: 2323483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cost-Effectiveness Analysis of Teleglaucoma Screening Device.
    Thomas S; Hodge W; Malvankar-Mehta M
    PLoS One; 2015; 10(9):e0137913. PubMed ID: 26382956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
    Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
    Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of glaucoma screening in cataract camps versus opportunistic and passive screening in urban India: A study protocol.
    Sabherwal S; John D; Dubey S; Mukherjee S; Menon GR; Majumdar A
    F1000Res; 2019; 8():53. PubMed ID: 31131093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of a community-based glaucoma detection programme: analysis of the Philadelphia Glaucoma Detection and Treatment Project.
    Pizzi LT; Waisbourd M; Hark L; Sembhi H; Lee P; Crews JE; Saaddine JB; Steele D; Katz LJ
    Br J Ophthalmol; 2018 Feb; 102(2):225-232. PubMed ID: 28655730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence and its screening methods of primary open angle glaucoma in defined population-based study of rural and urban in Beijing].
    Xu L; Chen JH; Li JJ; Luo L; Yang H; Zhang RX; Sun XY; Zheng YY; Song WX; Shi YY; Zhang SY; Sun BC; Zhao JL; Ma BR
    Zhonghua Yan Ke Za Zhi; 2004 Nov; 40(11):726-32. PubMed ID: 15634477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of primary angle-closure disease in an urban south Indian population and comparison with a rural population. The Chennai Glaucoma Study.
    Vijaya L; George R; Arvind H; Baskaran M; Ve Ramesh S; Raju P; Kumaramanickavel G; McCarty C
    Ophthalmology; 2008 Apr; 115(4):655-660.e1. PubMed ID: 17869343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of screening for open-angle glaucoma.
    Hernández RA; Burr JM; Vale LD;
    Int J Technol Assess Health Care; 2008; 24(2):203-11. PubMed ID: 18400124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of a community based prevention and treatment of acute malnutrition programme in Mumbai slums, India.
    Goudet S; Jayaraman A; Chanani S; Osrin D; Devleesschauwer B; Bogin B; Madise N; Griffiths P
    PLoS One; 2018; 13(11):e0205688. PubMed ID: 30412636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
    Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
    Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness and cost utility of an organized screening programme for glaucoma.
    Vaahtoranta-Lehtonen H; Tuulonen A; Aronen P; Sintonen H; Suoranta L; Kovanen N; Linna M; Läärä E; Malmivaara A
    Acta Ophthalmol Scand; 2007 Aug; 85(5):508-18. PubMed ID: 17655612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Screening for Open Angle Glaucoma Compared With Opportunistic Case Finding.
    Anton A; Serrano D; Nolivos K; Fatti G; Zmuc N; Crespo C; Monleon-Getino T; Sotelo K; Morilla A; García V; Comas M; Castells X
    J Glaucoma; 2023 Feb; 32(2):72-79. PubMed ID: 36696355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.